Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?

Tom Schalekamp; Anke-Hilse Maitland-van der Zee; Anthonius de Boer

Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?

Tom Schalekamp, Anke-Hilse Maitland-van der Zee, Anthonius de Boer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	175-176
Number of pages	2
Journal	Thrombosis and Haemostasis
Volume	100
Issue number	2
Publication status	Published - Aug 2008

Keywords

Anticoagulants
Aryl Hydrocarbon Hydroxylases
Coumarins
Cytochrome P-450 CYP2C9
Drug Resistance
Hemorrhage
Humans
Pharmacogenetics
Risk Factors

Cite this

@article{b372a8443fb64824a2178e9322087e51,

title = "Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?",

keywords = "Anticoagulants, Aryl Hydrocarbon Hydroxylases, Coumarins, Cytochrome P-450 CYP2C9, Drug Resistance, Hemorrhage, Humans, Pharmacogenetics, Risk Factors",

author = "Tom Schalekamp and {Maitland-van der Zee}, Anke-Hilse and {de Boer}, Anthonius",

year = "2008",

month = aug,

language = "English",

volume = "100",

pages = "175--176",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Schattauer GmbH",

number = "2",

}

TY - JOUR

T1 - Pharmacogenomics of coumarin anticoagulants

T2 - are we underestimating the role of CYP2C9?

AU - Schalekamp, Tom

AU - Maitland-van der Zee, Anke-Hilse

AU - de Boer, Anthonius

PY - 2008/8

Y1 - 2008/8

KW - Anticoagulants

KW - Aryl Hydrocarbon Hydroxylases

KW - Coumarins

KW - Cytochrome P-450 CYP2C9

KW - Drug Resistance

KW - Hemorrhage

KW - Humans

KW - Pharmacogenetics

KW - Risk Factors

M3 - Article

C2 - 18690332

SN - 0340-6245

VL - 100

SP - 175

EP - 176

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 2

ER -